{"id":"https://openalex.org/W2036617165","doi":"https://doi.org/10.1016/j.ejps.2007.05.068","title":"Microtensiometry\u2014A novel tool for fast drug solubility screening in 96-well plates","display_name":"Microtensiometry\u2014A novel tool for fast drug solubility screening in 96-well plates","publication_year":2007,"publication_date":"2007-06-28","ids":{"openalex":"https://openalex.org/W2036617165","doi":"https://doi.org/10.1016/j.ejps.2007.05.068","mag":"2036617165"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2007.05.068","doi":"https://doi.org/10.1016/j.ejps.2007.05.068","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2007.05.068","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"L. Peltonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"L. Peltonen","raw_affiliation_strings":["Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048935320","display_name":"Saila Taskinen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"S. Taskinen","raw_affiliation_strings":["Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024426748","display_name":"Jouni J. Hirvonen","orcid":"https://orcid.org/0000-0002-5029-1657","observed_orcids":["https://orcid.org/0000-0002-5029-1657"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"J. Hirvonen","raw_affiliation_strings":["Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, Faculty of Pharmacy, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I133731052"],"apc_list":{"value":3070,"currency":"USD","value_usd":3070},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"1","first_page":"S32","last_page":"S32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.06440000236034393,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.027899999171495438,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/taurine","display_name":"taurine","score":0.8420000076293945},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9959999918937683},{"id":"https://openalex.org/keywords/96-well-plate-screening","display_name":"96-well plate screening","score":0.7799999713897705},{"id":"https://openalex.org/keywords/field-potential-recording","display_name":"field potential recording","score":0.45500001311302185},{"id":"https://openalex.org/keywords/prelimbic-cortex","display_name":"prelimbic cortex","score":0.703000009059906},{"id":"https://openalex.org/keywords/mk-801-binding","display_name":"MK-801 binding","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C2779701627","wikidata":"https://www.wikidata.org/wiki/Q207051","display_name":"Taurine","level":3,"score":0.8584952354431152},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.8198337554931641},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6024760007858276},{"id":"https://openalex.org/C2777725853","wikidata":"https://www.wikidata.org/wiki/Q194406","display_name":"Strychnine","level":2,"score":0.5938048362731934},{"id":"https://openalex.org/C35599011","wikidata":"https://www.wikidata.org/wiki/Q426887","display_name":"Glycine receptor","level":4,"score":0.557469367980957},{"id":"https://openalex.org/C2779324764","wikidata":"https://www.wikidata.org/wiki/Q416602","display_name":"Picrotoxin","level":4,"score":0.5494911670684814},{"id":"https://openalex.org/C2777756961","wikidata":"https://www.wikidata.org/wiki/Q620730","display_name":"Glycine","level":3,"score":0.5148469805717468},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4569022059440613},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.44837531447410583},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4118392765522003},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.34801238775253296},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33442026376724243},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.29869329929351807},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.2692906856536865},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1631372570991516}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ejps.2007.05.068","doi":"https://doi.org/10.1016/j.ejps.2007.05.068","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2007.05.068","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320322192","display_name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","ror":"https://ror.org/02ks8qq67"},{"id":"https://openalex.org/F4320326184","display_name":"Hungarian Science Foundation","ror":"https://ror.org/017aqg979"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019591728","https://openalex.org/W2029799166","https://openalex.org/W1989304454","https://openalex.org/W2057916012","https://openalex.org/W1972413828","https://openalex.org/W136834585","https://openalex.org/W250172653","https://openalex.org/W2060014260","https://openalex.org/W329720538","https://openalex.org/W2140597415"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}